Clinical Trials Browser

Phase 3 × dinutuximab × Sarcoma × Clear all

NCT06669013 2024-11-01

FollowTheDIN

Phase 3 Recruiting

Bone Neoplasms, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal